Interleukin-22 Suppresses Growth of Renal Cell Carcinoma Cells
Author Information
Author(s): Zhang Fengbo, Shang Donghao, Zhang Yuhai, Tian Ye
Primary Institution: Beijing Friendship Hospital, Capital Medical University, Beijing, China
Hypothesis
The study aims to assess the inhibitory effects of interleukin-22 on human renal cell carcinoma cell line A498 and investigate the underlying mechanisms.
Conclusion
Interleukin-22 suppresses the growth of renal cell carcinoma cells and induces cell cycle arrest without causing apoptosis.
Supporting Evidence
- IL-22 suppressed the growth of A498 cells in a dose-dependent manner.
- IL-22 induced G2/M cell cycle arrest without causing apoptosis.
- The phosphorylation of STAT1 was increased in A498 cells exposed to IL-22.
Takeaway
Interleukin-22 helps stop kidney cancer cells from growing and makes them stop dividing, but it doesn't kill them.
Methodology
The study used MTT assay and flow cytometric analysis in vitro, and BALB/C nude mice with A498 cell xenografts in vivo.
Limitations
The study was conducted on a single cell line and may not be generalizable to all renal cell carcinoma types.
Participant Demographics
BALB/C nude mice were used for in vivo experiments.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website